Dosing Considerations and Bioavailability Assessment of Controlled Drug Delivery Systems
- 30 January 1987
- book chapter
- Published by Taylor & Francis
- p. 253-291
- https://doi.org/10.1201/b14193-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline ProductsClinical Pharmacokinetics, 1984
- Oral controlled drug administration, Pharmacokinetic ConsiderationsDrug Development and Industrial Pharmacy, 1983
- Controlled entry of orally administereddrugs: physiological considerationsDrug Development and Industrial Pharmacy, 1983
- Biopharmaceutics Aspects of the Regulatory Review of Oral Controlled-Release Drug ProductsDrug Development and Industrial Pharmacy, 1983
- Bioavailability of Tolazamide from Tablets: Comparison of In Vitro and In Vivo ResultsJournal of Pharmaceutical Sciences, 1982
- Drug delivery systemsPharmacology & Therapeutics, 1981
- Further Considerations on Model-Independent Bioavailability EstimationJournal of Pharmaceutical Sciences, 1980
- Blood Levels from a Sustained-Release Dosage FormJournal of Pharmaceutical Sciences, 1975
- Potential source of error in absorption rate calculationsJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Per Cent Absorbed Time Plots Derived from Blood Level and/or Urinary Excretion DataJournal of Pharmaceutical Sciences, 1963